Vicarious Surgical Advances Cost Restructuring and Nasdaq Relisting Strategy While Progressing Toward Surgical Robot Milestone

17 March 2026 | News

Robotics surgery developer cuts projected 2026 cash burn to $19M, applies for Nasdaq Capital Market listing, and targets system design freeze for its next-generation surgical platform by year-end.

Subscribe to our newsletter

Monthly digest of what's new and exciting from us.

We'll never share your email with anyone else.